EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Common DNA Damage Response Factors Required for Cellular Resistance to Inhibitors for the Ataxia Telangiectasia and Rad3-Related Checkpoint Kinase in Hematopoietic Cells

Muhammad Tufail, Ryotaro Kawasumi iD, Sangita Dattatray Shinde, Sivapriya Kirubakaran iD, Kouji Hirota iD

Biomolecules · 10.06.2026 · 16 (6) · 851

DOI: 10.3390/biom16060851 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, online erschienen am 10.06.2026. Verfasst von Muhammad Tufail und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Graduate School of Science, Tokyo Metropolitan University, Minamiosawa 1-1, Hachioji-shi 192-0397, Tokyo, Japan. Hauptthemen laut MEDLINE: Ataxia Telangiectasia Mutated Proteins, DNA Damage, Protein Kinase Inhibitors, Drug Resistance, Neoplasm. Die Arbeit nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Tokyo Metropolitan Government, Takeda Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Targeting checkpoints is one of the most promising strategies in cancer chemotherapy. Leukemia, in particular, is expected to yield high therapeutic efficacy due to its high replication stress. However, the DNA damage response factors involved in the vulnerability to checkpoint inhibitors of these hematopoietic cancers remain elusive. In this study, we reveal common factors required for cellular resistance to ATR inhibition in hematopoietic cancer cells. We explored the DNA damage response pathways contributing to cellular tolerance to three types of ATR inhibitors using an isogenic DNA repair factor mutant collection derived from the chicken lymphoma cell line, DT40. We first demonstrated significant ATR inhibition activity of the recently developed Torin2 analogous compounds, SPK67 and SPK98, under stressed replication conditions. We then compared cellular sensitivity patterns of the known ATR inhibitor, VE-821, and the potential ATR inhibitors, SPK67 and SPK98, in 24 types of mutants deficient in genome maintenance systems and found that RAD17/−, FEN1−/−, and POLB−/− cells exhibited hypersensitivity to all these drugs. Consistently, these mutant cells exhibited increased chromosome instability upon treatment with VE-821, SPK67, and SPK98, resulting in apoptosis. These results suggest that Rad17, Fen1, and Polymerase β play roles in responding to DNA damage caused by these drugs. However, ATR inhibition did not result in cell-cycle arrest, Chk1 phosphorylation, or increased γH2AX levels. These results suggest that, although ATR inhibition causes DNA damage, impaired checkpoint function suppresses the appropriate activation of DNA damage signaling pathways, thereby leading to cell death. This study is the first to demonstrate the importance of Rad17, Fen1, and Polymerase β in cellular tolerance to ATR inhibition in hematopoietic cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ataxia Telangiectasia Mutated ProteinsDNA DamageProtein Kinase InhibitorsDrug Resistance, NeoplasmHumansAnimalsChickensCell Line, TumorCheckpoint Kinase 1PyrazinesSulfones

Stichwörter der Autor:innen

DNA damage response (DDR)DNA replicationDT40TK6cancer chemotherapycheckpoint

Substanzen

Ataxia Telangiectasia Mutated ProteinsProtein Kinase InhibitorsATR protein, humanCheckpoint Kinase 1Pyrazines3-amino-6-(4-(methylsulfonyl)phenyl)-N-phenylpyrazine-2-carboxamideSulfones

Autor:innen und Institutionen

  • Department of Chemistry, Graduate School of Science, Tokyo Metropolitan University, Minamiosawa 1-1, Hachioji-shi 192-0397, Tokyo, Japan.
  • Department of Chemistry, Indian Institute of Technology Gandhinagar, Palaj, Gandhinagar 382055, Gujarat, India.

ORCID-Profile: Ryotaro Kawasumi, Sivapriya Kirubakaran, Kouji Hirota

Förderung

  • Japan Society for the Promotion of Science
  • Tokyo Metropolitan Government
  • Takeda Science Foundation
  • Uehara Memorial Foundation
  • Kankuben Bakshirambhai Gelot Chair

Zitieren

APA

Tufail, M., Kawasumi, R., Shinde, S. D., Kirubakaran, S., & Hirota, K. (2026). Common DNA Damage Response Factors Required for Cellular Resistance to Inhibitors for the Ataxia Telangiectasia and Rad3-Related Checkpoint Kinase in Hematopoietic Cells. Biomolecules, 16(6), 851. https://doi.org/10.3390/biom16060851

Vancouver

Tufail M, Kawasumi R, Shinde SD, Kirubakaran S, Hirota K. Common DNA Damage Response Factors Required for Cellular Resistance to Inhibitors for the Ataxia Telangiectasia and Rad3-Related Checkpoint Kinase in Hematopoietic Cells. Biomolecules. 2026;16(6):851. doi:10.3390/biom16060851

BibTeX
@article{Tufail2026,
  author = {Tufail, Muhammad and Kawasumi, Ryotaro and Shinde, Sangita Dattatray and Kirubakaran, Sivapriya and Hirota, Kouji},
  title = {Common DNA Damage Response Factors Required for Cellular Resistance to Inhibitors for the Ataxia Telangiectasia and Rad3-Related Checkpoint Kinase in Hematopoietic Cells},
  journal = {Biomolecules},
  year = {2026},
  volume = {16},
  number = {6},
  pages = {851},
  doi = {10.3390/biom16060851}
}
Kostenlos starten →